US Stock MarketDetailed Quotes

AKYA Akoya Biosciences

Watchlist

3.140
+0.080+2.61%

Close Oct 18 16:00 ET

3.140
0.0000.00%

Post 20:01 ET

155.43MMarket Cap-2683P/E (TTM)

Akoya Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

6.46%-11.04M

-5.40%-20.82M

4.85%-50.9M

44.20%-5.58M

-13.00%-13.75M

11.82%-11.8M

-10.18%-19.76M

-48.32%-53.5M

-70.94%-10.01M

9.14%-12.17M

Net income from continuing operations

36.79%-13.15M

-24.90%-23.48M

10.36%-63.32M

42.77%-10.8M

27.73%-12.92M

-18.91%-20.8M

-14.65%-18.8M

-64.53%-70.64M

-6.80%-18.88M

-53.84%-17.87M

Operating gains losses

----

-67.46%82K

--0

----

Depreciation and amortization

-7.71%1.93M

-3.30%2.05M

24.35%8.89M

10.78%2.11M

32.85%2.58M

23.49%2.09M

31.01%2.12M

49.19%7.15M

38.36%1.9M

55.87%1.94M

Deferred tax

--0

--37K

-245.71%-51K

20.31%-51K

--0

122.58%35K

46.22%-64K

--0

Other non cash items

-0.95%1.26M

49.25%1.5M

203.18%7.63M

-53.51%1.69M

311.43%3.67M

154.86%1.27M

228.85%1M

0.68%2.52M

221.22%3.63M

169.49%892K

Change In working capital

-559.15%-3.79M

-27.36%-8.22M

-9,562.75%-14.48M

-181.40%-1.09M

-1,001.63%-7.76M

-72.18%825K

-28.69%-6.45M

103.35%153K

-83.31%1.34M

119.17%861K

-Change in receivables

-4,802.60%-3.62M

197.88%3.15M

-2,449.12%-7.27M

14.39%-898K

-280.25%-3.23M

-90.86%77K

-71.87%-3.21M

90.42%-285K

-751.55%-1.05M

223.84%1.79M

-Change in inventory

41.48%-2.29M

-5,235.77%-7.31M

-17.83%-6.33M

150.64%708K

-2,032.26%-3M

-111.82%-3.91M

94.01%-137K

-16.12%-5.37M

40.66%-1.4M

-41.95%155K

-Change in prepaid assets

592.57%862K

-99.84%4K

182.83%2.26M

-127.54%-290K

-74.60%205K

-296.63%-175K

318.68%2.52M

109.08%798K

361.84%1.05M

127.14%807K

-Change in payables and accrued expense

-64.97%1.7M

46.28%-3.16M

-158.05%-2.33M

-105.49%-236K

47.55%-1.06M

128.34%4.85M

-1,461.27%-5.89M

-63.02%4.02M

-55.56%4.3M

-271.88%-2.02M

-Change in other current liabilities

-1.14%-532K

-2.41%-552K

-44.76%-2.29M

76.06%-623K

-70.90%-605K

-129.73%-526K

-35.77%-539K

---1.58M

---2.6M

---354K

-Change in other working capital

-82.05%91K

-142.15%-341K

-42.30%1.49M

-76.06%249K

-115.91%-77K

10.70%507K

35.51%809K

168.09%2.58M

220.99%1.04M

133.82%484K

Cash from discontinued investing activities

Operating cash flow

6.46%-11.04M

-5.40%-20.82M

4.85%-50.9M

44.20%-5.58M

-13.00%-13.75M

11.82%-11.8M

-10.18%-19.76M

-48.32%-53.5M

-70.94%-10.01M

9.14%-12.17M

Investing cash flow

Cash flow from continuing investing activities

736.26%9.05M

-887.88%-48.82M

123.77%3.35M

-102.68%-594K

-111.45%-832K

96.64%-1.42M

644.46%6.2M

-176.38%-14.08M

1,721.32%22.13M

487.52%7.27M

Net PPE purchase and sale

88.05%-170K

-0.75%-810K

49.99%-3.65M

31.65%-594K

77.72%-832K

9.02%-1.42M

29.35%-804K

-43.40%-7.31M

36.34%-869K

-99.15%-3.73M

Net investment purchase and sale

--9.22M

-785.81%-48.01M

203.34%7M

--0

--7M

---6.77M

--23M

--11M

Cash from discontinued investing activities

Investing cash flow

736.26%9.05M

-887.88%-48.82M

123.77%3.35M

-102.68%-594K

-111.45%-832K

96.64%-1.42M

644.46%6.2M

-176.38%-14.08M

1,721.32%22.13M

487.52%7.27M

Financing cash flow

Cash flow from continuing financing activities

-104.59%-2.13M

-5.97%-444K

97.88%56.84M

7.86%11.08M

-101.43%-141K

434.52%46.33M

-490.14%-419K

-79.04%28.73M

6,792.62%10.27M

22,509.09%9.86M

Net issuance payments of debt

0.00%-173K

-22.30%-181K

-65.48%10.57M

-0.15%11.07M

-101.78%-175K

-101.76%-173K

-17.46%-148K

9,612.11%30.63M

15,498.61%11.09M

13,421.62%9.86M

Net common stock issuance

----

--47.97M

---28K

---76K

----

--0

Proceeds from stock option exercised by employees

-83.92%23K

-37.93%36K

-22.60%346K

-81.38%35K

175.00%110K

-12.80%143K

5.45%58K

13.45%447K

-14.93%188K

33.33%40K

Net other financing activities

-15.23%-1.98M

9.12%-299K

13.06%-2.04M

--0

---1.71M

---329K

-47.80%-2.35M

---1.01M

---38K

Cash from discontinued financing activities

Financing cash flow

-104.59%-2.13M

-5.97%-444K

97.88%56.84M

7.86%11.08M

-101.43%-141K

434.52%46.33M

-490.14%-419K

-79.04%28.73M

6,792.62%10.27M

22,509.09%9.86M

Net cash flow

Beginning cash position

-77.31%13.74M

12.47%83.82M

-34.26%74.53M

51.38%78.93M

98.48%93.65M

-35.75%60.55M

-34.26%74.53M

547.60%113.38M

-56.71%52.14M

-65.25%47.18M

Current changes in cash

-112.42%-4.11M

-401.29%-70.09M

123.92%9.29M

-78.12%4.9M

-397.19%-14.73M

170.34%33.1M

26.96%-13.98M

-140.52%-38.85M

416.75%22.39M

132.36%4.96M

End cash Position

-89.72%9.63M

-77.31%13.74M

12.47%83.82M

51.38%78.93M

98.48%93.65M

-35.75%60.55M

-34.26%74.53M

-56.71%52.14M

Free cash flow

15.24%-11.21M

-5.21%-21.63M

10.36%-54.55M

43.20%-6.18M

8.62%-14.59M

11.53%-13.23M

-7.82%-20.56M

-47.85%-60.86M

-50.66%-10.88M

-4.52%-15.96M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	6.46%-11.04M	-5.40%-20.82M	4.85%-50.9M	44.20%-5.58M	-13.00%-13.75M	11.82%-11.8M	-10.18%-19.76M	-48.32%-53.5M	-70.94%-10.01M	9.14%-12.17M
Net income from continuing operations	36.79%-13.15M	-24.90%-23.48M	10.36%-63.32M	42.77%-10.8M	27.73%-12.92M	-18.91%-20.8M	-14.65%-18.8M	-64.53%-70.64M	-6.80%-18.88M	-53.84%-17.87M
Operating gains losses	----	----	----	----	----	----	----	-67.46%82K	--0	----
Depreciation and amortization	-7.71%1.93M	-3.30%2.05M	24.35%8.89M	10.78%2.11M	32.85%2.58M	23.49%2.09M	31.01%2.12M	49.19%7.15M	38.36%1.9M	55.87%1.94M
Deferred tax	--0	--37K	-245.71%-51K	20.31%-51K	--0	--0	--0	122.58%35K	46.22%-64K	--0
Other non cash items	-0.95%1.26M	49.25%1.5M	203.18%7.63M	-53.51%1.69M	311.43%3.67M	154.86%1.27M	228.85%1M	0.68%2.52M	221.22%3.63M	169.49%892K
Change In working capital	-559.15%-3.79M	-27.36%-8.22M	-9,562.75%-14.48M	-181.40%-1.09M	-1,001.63%-7.76M	-72.18%825K	-28.69%-6.45M	103.35%153K	-83.31%1.34M	119.17%861K
-Change in receivables	-4,802.60%-3.62M	197.88%3.15M	-2,449.12%-7.27M	14.39%-898K	-280.25%-3.23M	-90.86%77K	-71.87%-3.21M	90.42%-285K	-751.55%-1.05M	223.84%1.79M
-Change in inventory	41.48%-2.29M	-5,235.77%-7.31M	-17.83%-6.33M	150.64%708K	-2,032.26%-3M	-111.82%-3.91M	94.01%-137K	-16.12%-5.37M	40.66%-1.4M	-41.95%155K
-Change in prepaid assets	592.57%862K	-99.84%4K	182.83%2.26M	-127.54%-290K	-74.60%205K	-296.63%-175K	318.68%2.52M	109.08%798K	361.84%1.05M	127.14%807K
-Change in payables and accrued expense	-64.97%1.7M	46.28%-3.16M	-158.05%-2.33M	-105.49%-236K	47.55%-1.06M	128.34%4.85M	-1,461.27%-5.89M	-63.02%4.02M	-55.56%4.3M	-271.88%-2.02M
-Change in other current liabilities	-1.14%-532K	-2.41%-552K	-44.76%-2.29M	76.06%-623K	-70.90%-605K	-129.73%-526K	-35.77%-539K	---1.58M	---2.6M	---354K
-Change in other working capital	-82.05%91K	-142.15%-341K	-42.30%1.49M	-76.06%249K	-115.91%-77K	10.70%507K	35.51%809K	168.09%2.58M	220.99%1.04M	133.82%484K
Cash from discontinued investing activities
Operating cash flow	6.46%-11.04M	-5.40%-20.82M	4.85%-50.9M	44.20%-5.58M	-13.00%-13.75M	11.82%-11.8M	-10.18%-19.76M	-48.32%-53.5M	-70.94%-10.01M	9.14%-12.17M
Investing cash flow
Cash flow from continuing investing activities	736.26%9.05M	-887.88%-48.82M	123.77%3.35M	-102.68%-594K	-111.45%-832K	96.64%-1.42M	644.46%6.2M	-176.38%-14.08M	1,721.32%22.13M	487.52%7.27M
Net PPE purchase and sale	88.05%-170K	-0.75%-810K	49.99%-3.65M	31.65%-594K	77.72%-832K	9.02%-1.42M	29.35%-804K	-43.40%-7.31M	36.34%-869K	-99.15%-3.73M
Net investment purchase and sale	--9.22M	-785.81%-48.01M	203.34%7M	--0	--0	--0	--7M	---6.77M	--23M	--11M
Cash from discontinued investing activities
Investing cash flow	736.26%9.05M	-887.88%-48.82M	123.77%3.35M	-102.68%-594K	-111.45%-832K	96.64%-1.42M	644.46%6.2M	-176.38%-14.08M	1,721.32%22.13M	487.52%7.27M
Financing cash flow
Cash flow from continuing financing activities	-104.59%-2.13M	-5.97%-444K	97.88%56.84M	7.86%11.08M	-101.43%-141K	434.52%46.33M	-490.14%-419K	-79.04%28.73M	6,792.62%10.27M	22,509.09%9.86M
Net issuance payments of debt	0.00%-173K	-22.30%-181K	-65.48%10.57M	-0.15%11.07M	-101.78%-175K	-101.76%-173K	-17.46%-148K	9,612.11%30.63M	15,498.61%11.09M	13,421.62%9.86M
Net common stock issuance	----	----	--47.97M	---28K	---76K	----	----	--0	--0	--0
Proceeds from stock option exercised by employees	-83.92%23K	-37.93%36K	-22.60%346K	-81.38%35K	175.00%110K	-12.80%143K	5.45%58K	13.45%447K	-14.93%188K	33.33%40K
Net other financing activities	-15.23%-1.98M	9.12%-299K	13.06%-2.04M	--0	--0	---1.71M	---329K	-47.80%-2.35M	---1.01M	---38K
Cash from discontinued financing activities
Financing cash flow	-104.59%-2.13M	-5.97%-444K	97.88%56.84M	7.86%11.08M	-101.43%-141K	434.52%46.33M	-490.14%-419K	-79.04%28.73M	6,792.62%10.27M	22,509.09%9.86M
Net cash flow
Beginning cash position	-77.31%13.74M	12.47%83.82M	-34.26%74.53M	51.38%78.93M	98.48%93.65M	-35.75%60.55M	-34.26%74.53M	547.60%113.38M	-56.71%52.14M	-65.25%47.18M
Current changes in cash	-112.42%-4.11M	-401.29%-70.09M	123.92%9.29M	-78.12%4.9M	-397.19%-14.73M	170.34%33.1M	26.96%-13.98M	-140.52%-38.85M	416.75%22.39M	132.36%4.96M
End cash Position	-89.72%9.63M	-77.31%13.74M	12.47%83.82M	12.47%83.82M	51.38%78.93M	98.48%93.65M	-35.75%60.55M	-34.26%74.53M	-34.26%74.53M	-56.71%52.14M
Free cash flow	15.24%-11.21M	-5.21%-21.63M	10.36%-54.55M	43.20%-6.18M	8.62%-14.59M	11.53%-13.23M	-7.82%-20.56M	-47.85%-60.86M	-50.66%-10.88M	-4.52%-15.96M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data